SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)October 29, 2004
IMPAC Medical Systems, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 000-50082 | 94-3109238 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
100 West Evelyn Avenue, Mountain View, CA | 94041 | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (650) 623-8800
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):
¨ | Written communication pursuant to Rule 425 under the Securities Ac (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. 13e-4(c)) |
Item 8.01. Other Events.
On October 29, 2004, the Company issued a press release announcing that it had filed a Form 10-K/A for the fiscal year ended September 30, 2003 with the Securities and Exchange Commission. A copy of the press release is attached as Exhibit 99.1.
The Company also announced that it currently expects to file its restated Forms 10-Q/A for the first and second quarters of fiscal 2004 and Form 10-Q for the third quarter of fiscal 2004 by December 3, 2004, once the Company’s new auditors have completed their review of the fiscal 2004 quarterly results. However, no assurance can be given that these filings will be made at that time.
Item 9.01. Financial Statements and Exhibits.
(c) | Exhibits. |
99.1 | IMPAC Medical Systems, Inc. Press Release dated October 29, 2004. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IMPAC MEDICAL SYSTEMS, INC. | ||
By: | /s/ KENDRA A. BORREGO | |
Kendra A. Borrego | ||
Chief Financial Officer |
Date: November 2, 2004
3
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | IMPAC Medical Systems, Inc. Press Release dated October 29, 2004. |